DCLK1 and familial pancreatic carcinoma: Collectively, these findings reveal that glycolysis‐related ROS regulate the CSC and EMT phenotypes by targeting DCLK1 in GR cells, suggesting that DCLK1 is a promising target in treating pancreatic cancer.